GeneDx Holdings Corp. Class A Common Stock
WGS Real Time Price USDRecent trades of WGS by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by WGS's directors and management
Government lobbying spending instances
-
$17,500 May 15, 2023 Issue: Medical/Disease Research/Clinical Labs
-
$17,500 Oct 17, 2022 Issue: Medical/Disease Research/Clinical Labs
-
$35,000 Apr 20, 2022 Issue: Medical/Disease Research/Clinical Labs
Estimated quarterly lobbying spending
New patents grants
Federal grants, loans, and purchases
- $20,000 2024-06-28 00:00:00 Agency: Department of Health and Human Services
- $25,000 2024-05-03 00:00:00 Agency: Department of Health and Human Services
- $11,125 2023-09-25 00:00:00 Agency: Department of Health and Human Services
- $25,000 2023-08-07 00:00:00 Agency: Department of Health and Human Services
- $22,715 2022-12-16 00:00:00 Agency: DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS)
- $13,250 2022-12-16 00:00:00 Agency: DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS)
Estimated quarterly amount awarded from public contracts
Number of mentions of WGS in WallStreetBets Daily Discussion
Recent insights relating to WGS
Recent picks made for WGS stock on CNBC
ETFs with the largest estimated holdings in WGS
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view WGS Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.